PuraCath Medical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $999K

  • Investors
  • 14

PuraCath Medical General Information

Description

Developer of a dialysis disinfection device designed to reduce infectious complications associated with catheter connections. The company's device uses proprietary ultraviolet technology to keep patients healthy and protected from infection while minimizing dependence on user compliance, enabling healthcare providers to improve dialysis patients' quality of life by reducing infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 37600 Central Court
  • Suite 210
  • Newark, CA 94560
  • United States
+1 (650)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 37600 Central Court
  • Suite 210
  • Newark, CA 94560
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PuraCath Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 06-Jul-2023 $999K Completed Generating Revenue
11. Later Stage VC (Series A) 23-Jun-2020 Completed Generating Revenue
10. Grant 01-Feb-2020 Completed Generating Revenue
9. Grant 01-Jan-2020 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
7. Grant 01-Jan-2017 Completed Generating Revenue
6. Later Stage VC (Series A1) 31-Jan-2016 Completed Generating Revenue
5. Grant 02-Jun-2015 Completed Generating Revenue
4. Early Stage VC (Series A) 06-May-2013 $750K $750K Completed Startup
3. Grant 01-Jan-2012 $500K Completed Startup
To view PuraCath Medical’s complete valuation and funding history, request access »

PuraCath Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view PuraCath Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PuraCath Medical Patents

PuraCath Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3157269-A1 Point of care ultraviolet disinfection system Pending 04-Oct-2019
EP-4034220-A1 Point of care ultraviolet disinfection system Pending 04-Oct-2019
EP-4034220-A4 Point of care ultraviolet disinfection system Pending 04-Oct-2019
US-12016961-B2 Point of care ultraviolet disinfection system Active 04-Oct-2019
US-20210113725-A1 Point of care ultraviolet disinfection system Active 04-Oct-2019 A61L2/10
To view PuraCath Medical’s complete patent history, request access »

PuraCath Medical Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
TransPacific Venture Partners Venture Capital Minority
National Institutes of Health Government
National Institute for Allergy and Infectious Disease Government
You’re viewing 5 of 14 investors. Get the full list »

PuraCath Medical FAQs

  • When was PuraCath Medical founded?

    PuraCath Medical was founded in 2010.

  • Where is PuraCath Medical headquartered?

    PuraCath Medical is headquartered in Newark, CA.

  • What industry is PuraCath Medical in?

    PuraCath Medical’s primary industry is Other Devices and Supplies.

  • Is PuraCath Medical a private or public company?

    PuraCath Medical is a Private company.

  • What is PuraCath Medical’s current revenue?

    The current revenue for PuraCath Medical is .

  • How much funding has PuraCath Medical raised over time?

    PuraCath Medical has raised $4.22M.

  • Who are PuraCath Medical’s investors?

    , , TransPacific Venture Partners, National Institutes of Health, and National Institute for Allergy and Infectious Disease are 5 of 14 investors who have invested in PuraCath Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »